YME1L1, YME1 like 1 ATPase, 10730

N. diseases: 60; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0338508
Disease: Optic Atrophy 1
Optic Atrophy 1
0.030 Biomarker disease BEFREE Here we identified that ADCK1 utilizes YME1-like 1 ATPase (YME1L1) to control optic atrophy 1 (OPA1) and inner membrane mitochondrial protein (IMMT) in regulating mitochondrial dynamics and cristae structure. 31125351 2019
CUI: C0338508
Disease: Optic Atrophy 1
Optic Atrophy 1
0.030 AlteredExpression disease BEFREE The double AFG3L2/YME1L knockdown cells showed marked upregulation of OPA1 protein forms, with the most prominent increase in short OPA1 (optic atrophy 1). 30544562 2018
CUI: C0338508
Disease: Optic Atrophy 1
Optic Atrophy 1
0.030 Biomarker disease BEFREE <i>Opa1</i> ablation does not alter Δψ<sub>m</sub> fluctuations but drastically decreases the efficiency of mitopHlash/Δψ<sub>m</sub> coupling, which is restored by re-expressing fusion-deficient OPA1<sup>K301A</sup> and preserved in cells lacking the outer-membrane fusion proteins MFN1/2 or the OPA1 proteases OMA1 and YME1L, indicating that mitochondrial membrane fusion and OPA1 proteolytic processing are dispensable. pH/Δψ<sub>m</sub> uncoupling occurs early during staurosporine-induced apoptosis and is mitigated by OPA1 overexpression, suggesting that OPA1 maintains mitopHlash competence during stress conditions. 28174208 2017